nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—CYP3A4—chronic kidney failure	0.472	0.546	CbGaD
Topotecan—ABCB1—chronic kidney failure	0.393	0.454	CbGaD
Topotecan—Irinotecan—CYP2B6—chronic kidney failure	0.004	0.344	CrCbGaD
Topotecan—Irinotecan—ABCC2—chronic kidney failure	0.00348	0.299	CrCbGaD
Topotecan—Irinotecan—CYP3A4—chronic kidney failure	0.00154	0.132	CrCbGaD
Topotecan—TOP1MT—gonad—chronic kidney failure	0.00148	0.157	CbGeAlD
Topotecan—Irinotecan—ALB—chronic kidney failure	0.00134	0.115	CrCbGaD
Topotecan—Irinotecan—ABCB1—chronic kidney failure	0.00128	0.11	CrCbGaD
Topotecan—TOP1—nephron tubule—chronic kidney failure	0.000959	0.102	CbGeAlD
Topotecan—CYP3A4—urine—chronic kidney failure	0.000881	0.0936	CbGeAlD
Topotecan—TOP1—urethra—chronic kidney failure	0.000857	0.091	CbGeAlD
Topotecan—CYP3A4—Liver X Receptor Pathway—SREBF1—chronic kidney failure	0.000855	0.00753	CbGpPWpGaD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—chronic kidney failure	0.000849	0.00748	CbGpPWpGaD
Topotecan—TOP1—cortex of kidney—chronic kidney failure	0.000821	0.0872	CbGeAlD
Topotecan—CYP3A4—Liver X Receptor Pathway—FASN—chronic kidney failure	0.000814	0.00717	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.000809	0.00713	CbGpPWpGaD
Topotecan—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—chronic kidney failure	0.0008	0.00705	CbGpPWpGaD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—chronic kidney failure	0.000785	0.00691	CbGpPWpGaD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—chronic kidney failure	0.000768	0.00676	CbGpPWpGaD
Topotecan—CYP3A4—Xenobiotics—CYP2B6—chronic kidney failure	0.000762	0.00671	CbGpPWpGaD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—chronic kidney failure	0.000752	0.00663	CbGpPWpGaD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—chronic kidney failure	0.000736	0.00649	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PPARA—chronic kidney failure	0.000735	0.00647	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.000731	0.00644	CbGpPWpGaD
Topotecan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—chronic kidney failure	0.000729	0.00643	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—chronic kidney failure	0.000706	0.00622	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.000701	0.00618	CbGpPWpGaD
Topotecan—ABCB1—ABC-family proteins mediated transport—ABCC3—chronic kidney failure	0.000699	0.00616	CbGpPWpGaD
Topotecan—TOP1—blood—chronic kidney failure	0.000682	0.0724	CbGeAlD
Topotecan—ABCB1—ABC-family proteins mediated transport—ABCC2—chronic kidney failure	0.00067	0.0059	CbGpPWpGaD
Topotecan—CYP3A4—Xenobiotics—CYP2C18—chronic kidney failure	0.00066	0.00582	CbGpPWpGaD
Topotecan—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic kidney failure	0.000611	0.00538	CbGpPWpGaD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—chronic kidney failure	0.00061	0.00537	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—MTHFR—chronic kidney failure	0.000605	0.00533	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	0.0006	0.00529	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.000595	0.00524	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—ACAT1—chronic kidney failure	0.000591	0.0052	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EPO—chronic kidney failure	0.000557	0.0049	CbGpPWpGaD
Topotecan—CYP3A4—Xenobiotics—CYP2C19—chronic kidney failure	0.000547	0.00482	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—SERPINE1—chronic kidney failure	0.000547	0.00482	CbGpPWpGaD
Topotecan—CYP3A4—Tamoxifen metabolism—CYP2C19—chronic kidney failure	0.000526	0.00464	CbGpPWpGaD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—chronic kidney failure	0.000523	0.00461	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—chronic kidney failure	0.000514	0.00453	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—NAT8—chronic kidney failure	0.000509	0.00449	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.000498	0.00439	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	0.000498	0.00439	CbGpPWpGaD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—chronic kidney failure	0.000482	0.00425	CbGpPWpGaD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—chronic kidney failure	0.000473	0.00417	CbGpPWpGaD
Topotecan—CYP3A4—blood plasma—chronic kidney failure	0.00046	0.0488	CbGeAlD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.00046	0.00405	CbGpPWpGaD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—chronic kidney failure	0.000453	0.004	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.000452	0.00398	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.000451	0.00397	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.000432	0.00381	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	0.000432	0.00381	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—chronic kidney failure	0.000431	0.0038	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—ABCB1—chronic kidney failure	0.000405	0.00357	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—DDC—chronic kidney failure	0.000403	0.00355	CbGpPWpGaD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—chronic kidney failure	0.000399	0.00352	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EDN1—chronic kidney failure	0.000398	0.0035	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	0.000392	0.00345	CbGpPWpGaD
Topotecan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic kidney failure	0.000386	0.0034	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—chronic kidney failure	0.000382	0.00336	CbGpPWpGaD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—chronic kidney failure	0.000376	0.00331	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	0.00036	0.00317	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—CYP1A1—chronic kidney failure	0.000351	0.00309	CbGpPWpGaD
Topotecan—ABCG2—nephron tubule—chronic kidney failure	0.00034	0.0361	CbGeAlD
Topotecan—CYP3A4—Tryptophan metabolism—CYP2C18—chronic kidney failure	0.000339	0.00299	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	0.000336	0.00296	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	0.000333	0.00294	CbGpPWpGaD
Topotecan—ABCB1—blood plasma—chronic kidney failure	0.000325	0.0346	CbGeAlD
Topotecan—CYP3A4—Xenobiotics—CYP1A1—chronic kidney failure	0.000323	0.00284	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—chronic kidney failure	0.000316	0.00279	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000313	0.00276	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—chronic kidney failure	0.000312	0.00275	CbGpPWpGaD
Topotecan—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic kidney failure	0.00031	0.00273	CbGpPWpGaD
Topotecan—ABCG2—urethra—chronic kidney failure	0.000304	0.0323	CbGeAlD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EPO—chronic kidney failure	0.000301	0.00265	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic kidney failure	0.000297	0.00261	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.000278	0.00245	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—chronic kidney failure	0.000274	0.00242	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—chronic kidney failure	0.000271	0.00238	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—IL6—chronic kidney failure	0.00026	0.00229	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.000256	0.00226	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic kidney failure	0.000254	0.00224	CbGpPWpGaD
Topotecan—ABCG2—blood—chronic kidney failure	0.000242	0.0257	CbGeAlD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—chronic kidney failure	0.000241	0.00212	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.000229	0.00202	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.000227	0.002	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC34A1—chronic kidney failure	0.000225	0.00199	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.000224	0.00198	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.000222	0.00196	CbGpPWpGaD
Topotecan—CYP3A4—renal system—chronic kidney failure	0.000216	0.0229	CbGeAlD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic kidney failure	0.000215	0.00189	CbGpPWpGaD
Topotecan—CYP3A4—kidney—chronic kidney failure	0.000208	0.0221	CbGeAlD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000193	0.0017	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	0.000192	0.00169	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	0.000187	0.00165	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CAT—chronic kidney failure	0.000185	0.00163	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000184	0.00162	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	0.000178	0.00157	CbGpPWpGaD
Topotecan—CYP3A4—digestive system—chronic kidney failure	0.000177	0.0188	CbGeAlD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic kidney failure	0.000175	0.00154	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.000168	0.00148	CbGpPWpGaD
Topotecan—CYP3A4—blood—chronic kidney failure	0.000168	0.0179	CbGeAlD
Topotecan—ABCB1—nephron tubule—chronic kidney failure	0.000168	0.0178	CbGeAlD
Topotecan—CYP3A4—Tryptophan metabolism—CYP1A1—chronic kidney failure	0.000166	0.00146	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	0.000164	0.00145	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—chronic kidney failure	0.000155	0.00137	CbGpPWpGaD
Topotecan—ABCB1—renal system—chronic kidney failure	0.000153	0.0162	CbGeAlD
Topotecan—ABCB1—cardiovascular system—chronic kidney failure	0.000151	0.016	CbGeAlD
Topotecan—ABCB1—urethra—chronic kidney failure	0.00015	0.0159	CbGeAlD
Topotecan—ABCB1—kidney—chronic kidney failure	0.000148	0.0157	CbGeAlD
Topotecan—ABCB1—cortex of kidney—chronic kidney failure	0.000144	0.0153	CbGeAlD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic kidney failure	0.000137	0.00121	CbGpPWpGaD
Topotecan—ABCB1—gonad—chronic kidney failure	0.000137	0.0145	CbGeAlD
Topotecan—CYP3A4—Biological oxidations—CYP2B6—chronic kidney failure	0.000136	0.0012	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—GCKR—chronic kidney failure	0.000135	0.00119	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	0.000135	0.00119	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.000134	0.00118	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.000134	0.00118	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.000132	0.00116	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	0.000129	0.00114	CbGpPWpGaD
Topotecan—ABCB1—digestive system—chronic kidney failure	0.000125	0.0133	CbGeAlD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC34A1—chronic kidney failure	0.000122	0.00107	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FABP1—chronic kidney failure	0.000122	0.00107	CbGpPWpGaD
Topotecan—ABCB1—blood—chronic kidney failure	0.000119	0.0127	CbGeAlD
Topotecan—CYP3A4—Biological oxidations—CYP2C18—chronic kidney failure	0.000118	0.00104	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000116	0.00103	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GATM—chronic kidney failure	0.000115	0.00102	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AGXT—chronic kidney failure	0.000115	0.00102	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000109	0.000957	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ACAT1—chronic kidney failure	0.000106	0.00093	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	0.000104	0.000913	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	0.000101	0.00089	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	9.99e-05	0.00088	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MLXIPL—chronic kidney failure	9.81e-05	0.000865	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2C19—chronic kidney failure	9.79e-05	0.000862	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—chronic kidney failure	9.65e-05	0.00085	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2C19—chronic kidney failure	9.65e-05	0.00085	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	9.63e-05	0.000849	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic kidney failure	9.44e-05	0.000831	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC22A2—chronic kidney failure	8.98e-05	0.000791	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	8.95e-05	0.000789	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	8.89e-05	0.000783	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCG1—chronic kidney failure	8.34e-05	0.000735	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—chronic kidney failure	8.17e-05	0.00072	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIP5K1B—chronic kidney failure	8.17e-05	0.00072	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	8.09e-05	0.000713	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ARG2—chronic kidney failure	8e-05	0.000705	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LCAT—chronic kidney failure	7.85e-05	0.000691	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TGFB1—chronic kidney failure	7.5e-05	0.000661	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	7.3e-05	0.000643	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	7.3e-05	0.000643	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—DDC—chronic kidney failure	7.2e-05	0.000635	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—AVP—chronic kidney failure	7.09e-05	0.000625	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—chronic kidney failure	7e-05	0.000617	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	7e-05	0.000617	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PRKAG2—chronic kidney failure	6.99e-05	0.000616	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2B6—chronic kidney failure	6.99e-05	0.000616	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PRKD1—chronic kidney failure	6.99e-05	0.000616	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	6.87e-05	0.000605	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FABP1—chronic kidney failure	6.58e-05	0.00058	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SREBF2—chronic kidney failure	6.55e-05	0.000577	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GCKR—chronic kidney failure	6.32e-05	0.000557	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCC3—chronic kidney failure	6.32e-05	0.000557	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GATM—chronic kidney failure	6.24e-05	0.00055	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AGXT—chronic kidney failure	6.24e-05	0.00055	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPIN1—chronic kidney failure	6.19e-05	0.000545	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	6.17e-05	0.000544	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2C18—chronic kidney failure	6.06e-05	0.000534	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LRP2—chronic kidney failure	6.06e-05	0.000534	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	5.78e-05	0.00051	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	5.77e-05	0.000508	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACAT1—chronic kidney failure	5.71e-05	0.000503	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	5.69e-05	0.000501	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MLXIPL—chronic kidney failure	5.31e-05	0.000468	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CPT1A—chronic kidney failure	5.16e-05	0.000454	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	5.12e-05	0.000451	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LIPC—chronic kidney failure	5.02e-05	0.000443	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2C19—chronic kidney failure	5.02e-05	0.000443	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC22A2—chronic kidney failure	4.85e-05	0.000428	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SCARB1—chronic kidney failure	4.64e-05	0.000409	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS1—chronic kidney failure	4.59e-05	0.000405	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG1—chronic kidney failure	4.51e-05	0.000398	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SREBF1—chronic kidney failure	4.51e-05	0.000397	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	4.44e-05	0.000392	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIP5K1B—chronic kidney failure	4.41e-05	0.000389	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMGCR—chronic kidney failure	4.38e-05	0.000386	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ARG2—chronic kidney failure	4.33e-05	0.000381	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—POMC—chronic kidney failure	4.3e-05	0.000379	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—chronic kidney failure	4.3e-05	0.000379	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FASN—chronic kidney failure	4.29e-05	0.000378	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LCAT—chronic kidney failure	4.24e-05	0.000374	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FABP1—chronic kidney failure	4.06e-05	0.000357	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	4.03e-05	0.000355	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP3A4—chronic kidney failure	3.97e-05	0.00035	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCA1—chronic kidney failure	3.91e-05	0.000344	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DDC—chronic kidney failure	3.89e-05	0.000343	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GATM—chronic kidney failure	3.84e-05	0.000339	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AGXT—chronic kidney failure	3.84e-05	0.000339	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.83e-05	0.000338	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PRKD1—chronic kidney failure	3.78e-05	0.000333	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2B6—chronic kidney failure	3.78e-05	0.000333	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PRKAG2—chronic kidney failure	3.78e-05	0.000333	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	3.7e-05	0.000326	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SREBF2—chronic kidney failure	3.54e-05	0.000312	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACAT1—chronic kidney failure	3.52e-05	0.00031	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	3.46e-05	0.000305	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	3.43e-05	0.000302	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GCKR—chronic kidney failure	3.42e-05	0.000301	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCC3—chronic kidney failure	3.42e-05	0.000301	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPIN1—chronic kidney failure	3.35e-05	0.000295	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAT—chronic kidney failure	3.31e-05	0.000291	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LRP2—chronic kidney failure	3.28e-05	0.000289	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2C18—chronic kidney failure	3.28e-05	0.000289	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	3.27e-05	0.000288	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCB1—chronic kidney failure	3.22e-05	0.000284	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	3.13e-05	0.000275	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPL—chronic kidney failure	3.07e-05	0.00027	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	2.99e-05	0.000263	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1A1—chronic kidney failure	2.96e-05	0.000261	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CPT1A—chronic kidney failure	2.79e-05	0.000246	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG1—chronic kidney failure	2.78e-05	0.000245	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—chronic kidney failure	2.76e-05	0.000243	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	2.72e-05	0.00024	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LIPC—chronic kidney failure	2.72e-05	0.000239	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2C19—chronic kidney failure	2.72e-05	0.000239	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARA—chronic kidney failure	2.71e-05	0.000239	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ARG2—chronic kidney failure	2.66e-05	0.000235	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LCAT—chronic kidney failure	2.61e-05	0.00023	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SCARB1—chronic kidney failure	2.51e-05	0.000221	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS1—chronic kidney failure	2.48e-05	0.000219	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SREBF1—chronic kidney failure	2.44e-05	0.000215	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DDC—chronic kidney failure	2.4e-05	0.000211	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMGCR—chronic kidney failure	2.37e-05	0.000209	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	2.33e-05	0.000205	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	2.33e-05	0.000205	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PRKD1—chronic kidney failure	2.33e-05	0.000205	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.32e-05	0.000205	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FASN—chronic kidney failure	2.32e-05	0.000204	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—POMC—chronic kidney failure	2.21e-05	0.000195	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SREBF2—chronic kidney failure	2.18e-05	0.000192	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP3A4—chronic kidney failure	2.15e-05	0.000189	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCA1—chronic kidney failure	2.11e-05	0.000186	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GCKR—chronic kidney failure	2.11e-05	0.000186	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCC3—chronic kidney failure	2.11e-05	0.000186	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPIN1—chronic kidney failure	2.06e-05	0.000182	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LRP2—chronic kidney failure	2.02e-05	0.000178	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	2.02e-05	0.000178	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—chronic kidney failure	2.01e-05	0.000177	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—chronic kidney failure	1.93e-05	0.00017	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAT—chronic kidney failure	1.79e-05	0.000158	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—chronic kidney failure	1.76e-05	0.000155	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.72e-05	0.000151	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.67e-05	0.000147	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.67e-05	0.000147	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPL—chronic kidney failure	1.66e-05	0.000146	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1A1—chronic kidney failure	1.6e-05	0.000141	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.55e-05	0.000136	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.53e-05	0.000135	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.5e-05	0.000132	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—chronic kidney failure	1.49e-05	0.000132	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARA—chronic kidney failure	1.46e-05	0.000129	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.46e-05	0.000129	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FASN—chronic kidney failure	1.43e-05	0.000126	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.3e-05	0.000115	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—POMC—chronic kidney failure	1.19e-05	0.000105	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAT—chronic kidney failure	1.1e-05	9.71e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—chronic kidney failure	1.09e-05	9.59e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCB1—chronic kidney failure	1.07e-05	9.44e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—chronic kidney failure	1.04e-05	9.17e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPL—chronic kidney failure	1.02e-05	9e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	9.86e-06	8.69e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—chronic kidney failure	9.52e-06	8.39e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—chronic kidney failure	9.19e-06	8.1e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARA—chronic kidney failure	9.02e-06	7.95e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—POMC—chronic kidney failure	7.35e-06	6.48e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—chronic kidney failure	6.7e-06	5.91e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—chronic kidney failure	6.41e-06	5.65e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—chronic kidney failure	5.87e-06	5.17e-05	CbGpPWpGaD
